New late-breaking data to be presented today by the Australian and New Zealand Urogenital and Prostate (ANZUP) Clinical ...
A comprehensive review maps how MRI protocols and antibody testing are reshaping the diagnosis of childhood demyelinating ...
Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's IMFINZI® (durvalumab) reduced the risk of death by 58% ...
When Adrian Maxwell, a retired City of London Police detective and criminal barrister, stumbled on this timeless idyll he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results